首页> 外文期刊>The Journal of Chemical Thermodynamics >Remarks and further calculations on 'Solubility measurement, model evaluation and thermodynamic analysis of rivaroxaban polymorphs in organic solvents'
【24h】

Remarks and further calculations on 'Solubility measurement, model evaluation and thermodynamic analysis of rivaroxaban polymorphs in organic solvents'

机译:“有机溶剂中蓖麻毒性测量,模型评价和热力学分析”的备注及进一步计算

获取原文
获取原文并翻译 | 示例
       

摘要

The solubility of form II of anticoagulant drug rivaroxaban in a series of organic solvents was firstly reported by Zhai and coworkers [J. Chem. Thermodynamics 104 (2017) 218-229]. The three activity coefficient models (Wilson, NRTL and UNIQUAC equations) with the correlation between model parameters and temperature were employed to model the studied solid-liquid equilibrium. According to DSC thermograms, rivaroxaban form II has a phase transition between the experimental temperature and the melting point. The authors of published paper must take into consideration that the effect of phase transformation when calculating the activity coefficient of rivaroxaban form II. The Akaike Information Criterion (AIC) was used to compare the relative applicability of these models. (C) 2017 Published by Elsevier Ltd.
机译:Zhai和Codorkers首先报道了一系列有机溶剂中抗凝血药物抗凝血药物氧化芳基氧基甲烷的溶解度[J. 化学。 热力学104(2017)218-229]。 采用模型参数和温度之间的相关性的三种活性系数模型(Wilson,NRTL和Uniquac方程)来模拟研究的固液平衡。 根据DSC热分析图,Rivaroxaban形式II具有实验温度和熔点之间的相转变。 发表论文的作者必须考虑到计算氢冈南汉型II的活性系数时相变的影响。 Akaike信息标准(AIC)用于比较这些模型的相对适用性。 (c)2017年由elestvier有限公司出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号